A Randomized, Placebo-controlled Phase 2 Study of Arry-797 in Patients with Osteoarthritis Pain Refractory to Nsaid Treatment Showed Statistically Significant Improvements in Womac Pain and in Biomarkers of Bone and Cartilage Degradation.: L1